Related Experiment Video
Updated: Mar 3, 2026

07:13
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
1.0K
Protease-activated receptors in endothelial health and dysfunction
Kaushik Muralidharan1, Livia M Bogdan2, Bryce A Kerlin1,3
1Center for Clinical and Translational Research.
Current Opinion in Hematology
|March 2, 2026
Summary
Endothelial protease-activated receptors (PARs) act as sensors of vascular protease activity. Understanding their specific signaling pathways is key to developing targeted therapies for vascular diseases.
Area of Science:
- Vascular Biology
- Cell Signaling
- Protease-Activated Receptors
Background:
- Protease-activated receptors (PARs) link extracellular proteases to intracellular signals in endothelial cells.
- PARs are critical regulators of coagulation, inflammation, and vascular stability.
Purpose of the Study:
- To review recent advancements in understanding endothelial PAR1-PAR4 signaling.
- To explore how protease specificity, receptor interactions, and signaling bias influence endothelial responses in health and disease.
Main Methods:
- Literature review of recent research on endothelial PAR signaling.
- Analysis of protease specificity, receptor interactions, and signaling bias.
Main Results:
- Endothelial PAR signaling is context-dependent.
- PAR1 exhibits biased signaling; thrombin disrupts barriers, while activated protein C (aPC) protects via β-arrestin.
- PAR2 regulates endothelial inflammation and vasodilation.
- PAR3 acts as a regulator, forming heterodimers with PAR1.
- PAR4 activation leads to barrier dysfunction and thromboinflammation.
Conclusions:
- Endothelial PARs are sophisticated sensors of the vascular protease environment.
- Future therapies will focus on pathway-specific modulation rather than broad blocking.
- New avenues for precise vascular treatments are emerging.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
4.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.5K
Regulation of Angiogenesis and Blood Supply
3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Receptor Downregulation in MVBs
2.9K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.9K
Coronary Artery Disease II: Pathophysiology
817
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
817
Inflammation
62.9K
Overview
62.9K
Enzyme-linked Receptors
87.8K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
87.8K

